See All Slides - tctmd.com

Slides

Presentation TCT 2014

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Carl Schultz

September 15, 2014

Presentation TCT 2014

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul

September 15, 2014

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

September 15, 2014

Presentation TCT 2014

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Presenter: Warren Sherman, Wojtek Wojakowski, Stephen E. Epstein, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Presenter: Warren Sherman, Wojtek Wojakowski, Stephen E. Epstein, Maximilian Y Emmert

September 15, 2014

Presentation TCT 2014

Potential Role for a Self-Expanding Stent in Bifurcations: Final OPEN II Results

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Christoph K. Naber

September 15, 2014

Presentation TCT 2014

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Presenter: Dierk Scheinert

September 15, 2014

Presentation TCT 2014

Gene Therapy to Reverse Remodel the Failing Heart: State of the Art

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Krisztina Zsebo

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Fernando Alfonso

September 15, 2014

Advertisement

Slides

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

TCT 151: Transcatheter Transplantation and In Vivo Tracking Of Human Stem Cell-Based 3-Dimensional Microtissues in a Porcine Model Of Myocardial Infarction

Potential Role for a Self-Expanding Stent in Bifurcations: Final OPEN II Results

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Gene Therapy to Reverse Remodel the Failing Heart: State of the Art

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content